Cargando…
A quantitative multimodal metabolomic assay for colorectal cancer
BACKGROUND: Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves treatment outcomes. We previously described a diagnostic metabolomic biomarker derived from semi-quantitative gas chromatography-mass spectrometry. Our objective was to determine whether a quantitative assay of...
Autores principales: | Farshidfar, Farshad, Kopciuk, Karen A., Hilsden, Robert, McGregor, S. Elizabeth, Mazurak, Vera C., Buie, W. Donald, MacLean, Anthony, Vogel, Hans J., Bathe, Oliver F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755335/ https://www.ncbi.nlm.nih.gov/pubmed/29301511 http://dx.doi.org/10.1186/s12885-017-3923-z |
Ejemplares similares
-
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
por: Farshidfar, Farshad, et al.
Publicado: (2016) -
Serum metabolomic profile as a means to distinguish stage of colorectal cancer
por: Farshidfar, Farshad, et al.
Publicado: (2012) -
From Genotype to Functional Phenotype: Unraveling the Metabolomic Features of Colorectal Cancer
por: Bathe, Oliver F., et al.
Publicado: (2014) -
A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolome
por: Amin, Shahil, et al.
Publicado: (2019) -
A Framework for Development of Useful Metabolomic Biomarkers and Their Effective Knowledge Translation
por: Marchand, Calena R., et al.
Publicado: (2018)